Chronic hand eczema treatment: exploring topical JAK inhibition further The Lancet Source link
Scientists peel away the mystery of JAK enzymes, which play roles in everything from eczema to ulcerative colitis Medical Xpress Source link
JAK Inhibitors in Atopic Dermatitis MD Magazine Source link
Watch out, Incyte. Leo Pharma and its JAK inhibitor cream delgocitinib are coming to disrupt the topical atopic dermatitis market, currently inhibited by Incyte’s approved Opzelura. With several positive studies in hand, including a recent phase 3 trial pitting the candidate against the current standard-of-care, Leo says its delgocitinib has growth driver potential. Now, the drugmaker […]